The Microalbumin/Creatinine Ratio (ACR) is a critical diagnostic marker used primarily for evaluating kidney function, particularly in individuals at risk for kidney disease, such as those with diabetes or hypertension. This ratio is calculated by measuring the amount of albumin (a type of protein) and creatinine (a waste product) in a urine sample. Albumin is typically present in the blood and should be filtered and retained by healthy kidneys; however, when the kidneys are damaged, small amounts of albumin can leak into the urine, a condition known as microalbuminuria. Creatinine, produced at a relatively constant rate by muscle metabolism and excreted in the urine, serves as a benchmark for normalizing the amount of albumin excretion. The ACR compensates for variations in urine concentration and provides a more accurate assessment of kidney function than measuring albumin alone. A normal ACR suggests healthy kidney function, whereas an elevated ACR indicates microalbuminuria and is one of the earliest signs of kidney damage. Regular monitoring of the ACR is particularly important in managing chronic conditions like diabetes, where maintaining optimal blood sugar levels can help prevent or delay the onset of kidney damage. This ratio is also useful in identifying individuals at increased risk for cardiovascular diseases, as microalbuminuria is associated with a higher risk of cardiovascular complications. The simplicity, non-invasiveness, and cost-effectiveness of the ACR test make it a valuable tool in both screening for early kidney disease and monitoring the progression and treatment efficacy in individuals with established kidney disease.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.